GlaxoSmithKline Pharmaceuticals Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 |
|---|---|---|---|---|---|---|---|---|
| 1,011 | 949 | 974 | 805 | 980 | 1,041 | 995 | 938 | |
| 35 | 35 | 41 | 44 | 34 | 32 | 36 | 44 | |
| 706 | 676 | 656 | 570 | 662 | 691 | 658 | 660 | |
| 149 | 97 | 115 | 128 | 115 | 80 | 113 | 73 | |
| 217 | 164 | 291 | 232 | 233 | 217 | 228 | 379 | |
| 19 | 97 | −55 | −72 | 8 | 67 | 3 | −124 | |
| 151 | 125 | 153 | 153 | 138 | 152 | 165 | 159 | |
| 0.27 | 0.09 | 0.58 | 0.42 | 0.51 | 1 | 0.61 | 0.97 | |
| 17 | 19 | 15 | 16 | 17 | 20 | 13 | 16 | |
| 154 | 174 | 136 | 114 | 151 | 154 | 136 | 156 | |
| 361 | 327 | 374 | 295 | 372 | 421 | 387 | 339 | |
| 344 | 308 | 359 | 279 | 355 | 401 | 374 | 323 | |
| 5 | — | — | — | 3 | 18 | — | — | |
| 344 | 308 | 359 | 279 | 354 | 400 | 373 | 322 | |
| 91 | 78 | 96 | 74 | 97 | 104 | 95 | 85 | |
| 253 | 230 | 263 | 205 | 257 | 296 | 278 | 237 | |
| Financial ratios | ||||||||
| 35.71% | 34.44% | 38.37% | 36.63% | 37.96% | 40.47% | 38.87% | 36.15% | |
| 24.98% | 24.21% | 26.98% | 25.46% | 26.28% | 28.39% | 27.92% | 25.27% | |
| 14.67 | 13.57 | 15.52 | 12.10 | 15.07 | 16.54 | 16.40 | 14.00 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.